Announced Sat, 4 Jul · 11:27 IST
Promoter group creates indirect encumbrance on 47 percent of GTBL shares
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.1%1-day move
₹386.10
prior close
₹386.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
———+0.2-2.1-5.0-3.4-1.6-0.8-3.4-5.7———
Up moveDown movePending
AI summary
Promoter group entity Pharmaceutical Business Group (India) Ltd disclosed indirect encumbrance over 5,12,40,000 GTBL shares (47.02 percent of capital). Vividhmargi Investments pledged 51 percent of PBGIL shares and gave a non-disposal undertaking on 47.98 percent, in favour of debenture trustee CTL Trusteeship, linked to debentures of OSS Software Solutions Labs. Encumbered shares equal 66.36 percent of promoter holding. Rs 135 crore raised is for personal use by promoters and PACs.
Likely market impact
Negative — 47 percent of GTBL shares now indirectly encumbered; Rs 135 crore for promoter personal use raises governance concerns.